• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

真核生物拓扑异构酶II的作用机制及针对该酶的药物

Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme.

作者信息

Burden D A, Osheroff N

机构信息

Department of Biochemistry, 654 Medical Research Building I, Vanderbilt University School of Medicine, Nashville, TN 37232-0146, USA.

出版信息

Biochim Biophys Acta. 1998 Oct 1;1400(1-3):139-54. doi: 10.1016/s0167-4781(98)00132-8.

DOI:10.1016/s0167-4781(98)00132-8
PMID:9748545
Abstract

Topoisomerase II is a ubiquitous enzyme that is essential for the survival of all eukaryotic organisms and plays critical roles in virtually every aspect of DNA metabolism. The enzyme unknots and untangles DNA by passing an intact helix through a transient double-stranded break that it generates in a separate helix. Beyond its physiological functions, topoisomerase II is the target for some of the most active and widely prescribed anticancer drugs currently utilized for the treatment of human cancers. These drugs act in an insidious fashion and kill cells by increasing levels of covalent topoisomerase II-cleaved DNA complexes that are normally fleeting intermediates in the catalytic cycle of the enzyme. Over the past several years, we have made considerable strides in our understanding of the catalytic mechanism of topoisomerase II and the mechanism of action of drugs targeted to this enzyme. These advances have provided novel insights into the physiological functions of topoisomerase II and have led to the development of more efficacious chemotherapeutic regimens and novel anticancer drugs. Considering the importance of topoisomerase II to the eukaryotic cell and to cancer chemotherapy, it is essential to understand its enzymatic function and pharmacological properties. Therefore, this review will discuss the mechanism of action of eukaryotic topoisomerase II and topoisomerase II-targeted drugs.

摘要

拓扑异构酶II是一种普遍存在的酶,对所有真核生物的生存至关重要,并且在DNA代谢的几乎每个方面都发挥着关键作用。该酶通过使完整的螺旋穿过其在另一条螺旋中产生的瞬时双链断裂来解开和理顺DNA。除了其生理功能外,拓扑异构酶II还是目前用于治疗人类癌症的一些最活跃且处方广泛的抗癌药物的靶点。这些药物以一种隐匿的方式起作用,通过增加共价拓扑异构酶II切割的DNA复合物的水平来杀死细胞,这些复合物通常是该酶催化循环中的短暂中间体。在过去几年中,我们在理解拓扑异构酶II的催化机制以及靶向该酶的药物的作用机制方面取得了长足的进展。这些进展为拓扑异构酶II的生理功能提供了新的见解,并导致了更有效的化疗方案和新型抗癌药物的开发。鉴于拓扑异构酶II对真核细胞和癌症化疗的重要性,了解其酶功能和药理特性至关重要。因此,本综述将讨论真核拓扑异构酶II和靶向拓扑异构酶II的药物的作用机制。

相似文献

1
Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme.真核生物拓扑异构酶II的作用机制及针对该酶的药物
Biochim Biophys Acta. 1998 Oct 1;1400(1-3):139-54. doi: 10.1016/s0167-4781(98)00132-8.
2
Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice.作为抗癌药物靶点的拓扑异构酶II:当酶不再“友好”时。
Prog Nucleic Acid Res Mol Biol. 2000;64:221-53. doi: 10.1016/s0079-6603(00)64006-0.
3
Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes.真核生物拓扑异构酶II-DNA切割复合物的稳定作用。
Curr Top Med Chem. 2003;3(3):321-38. doi: 10.2174/1568026033452519.
4
Catalytic function of DNA topoisomerase II.DNA拓扑异构酶II的催化功能。
Bioessays. 1991 Jun;13(6):269-73. doi: 10.1002/bies.950130603.
5
The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing.拓扑异构酶II的DNA切割反应:披着羊皮的狼
Nucleic Acids Res. 2009 Feb;37(3):738-48. doi: 10.1093/nar/gkn937. Epub 2008 Nov 28.
6
Etoposide, topoisomerase II and cancer.依托泊苷、拓扑异构酶II与癌症
Curr Med Chem Anticancer Agents. 2005 Jul;5(4):363-72. doi: 10.2174/1568011054222364.
7
Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.溴化乙锭与DNA的共价连接导致拓扑异构酶II介导的DNA切割增强。
Biochemistry. 1997 Dec 16;36(50):15884-91. doi: 10.1021/bi971858c.
8
Analysis of eukaryotic DNA topoisomerases and topoisomerase-directed drug effects.真核生物DNA拓扑异构酶及拓扑异构酶导向药物效应分析。
Eur J Clin Chem Clin Biochem. 1996 Nov;34(11):873-88.
9
Cleavage of plasmid DNA by eukaryotic topoisomerase II.真核生物拓扑异构酶II对质粒DNA的切割
Methods Mol Biol. 2009;582:39-47. doi: 10.1007/978-1-60761-340-4_4.
10
A dual mechanism of action of the anticancer agent F 11782 on human topoisomerase II alpha.
Biochem Pharmacol. 2003 Aug 15;66(4):623-31. doi: 10.1016/s0006-2952(03)00342-3.

引用本文的文献

1
The Mediator Kinase Module regulates cell cycle re-entry and transcriptional responses following DNA damage.中介激酶模块调节DNA损伤后的细胞周期重新进入和转录反应。
bioRxiv. 2025 May 20:2023.02.26.530133. doi: 10.1101/2023.02.26.530133.
2
DNA Damage Response After Treatment of Cycling and Quiescent Cord Blood Hematopoietic Stem Cells With Distinct Genotoxic Noxae.用不同遗传毒性 Noxa 处理循环和静止脐带血造血干细胞后的 DNA 损伤反应。
Stem Cells. 2024 Feb 8;42(2):158-171. doi: 10.1093/stmcls/sxad085.
3
Novel 2-substituted-quinoxaline analogs with potential antiproliferative activity against breast cancer: insights into cell cycle arrest, topoisomerase II, and EGFR activity.
具有抗乳腺癌潜在增殖活性的新型2-取代喹喔啉类似物:对细胞周期阻滞、拓扑异构酶II和表皮生长因子受体活性的深入研究
RSC Adv. 2023 Nov 9;13(47):33080-33095. doi: 10.1039/d3ra06189b. eCollection 2023 Nov 7.
4
Loss of p53 activates thyroid hormone via type 2 deiodinase and enhances DNA damage.p53 失活通过 2 型脱碘酶激活甲状腺激素并增强 DNA 损伤。
Nat Commun. 2023 Mar 4;14(1):1244. doi: 10.1038/s41467-023-36755-y.
5
Antitumor activity of triazine mimic antibiotics for DNA-binding implications (impressive activity in vitro against a variety of tumor types in the NCI-60 screen): NSC 710607 to fight HCT-116 human colon carcinoma cell lines in vivo using the hollow fiber assay and xenograft mouse models.三嗪模拟抗生素的抗肿瘤活性及其对 DNA 结合的影响(在 NCI-60 筛选中对多种肿瘤类型具有显著的体外活性):NSC 710607 通过空心纤维测定和异种移植小鼠模型在体内对抗 HCT-116 人结肠癌细胞系。
J Cancer Res Clin Oncol. 2023 Aug;149(9):6501-6511. doi: 10.1007/s00432-023-04604-6. Epub 2023 Feb 13.
6
The Implication of Topoisomerase II Inhibitors in Synthetic Lethality for Cancer Therapy.拓扑异构酶II抑制剂在癌症治疗合成致死中的意义。
Pharmaceuticals (Basel). 2023 Jan 9;16(1):94. doi: 10.3390/ph16010094.
7
Recent Advances Regarding the Molecular Mechanisms of Triterpenic Acids: A Review (Part I).三萜酸的分子机制研究进展:综述(第一部分)。
Int J Mol Sci. 2022 Jul 13;23(14):7740. doi: 10.3390/ijms23147740.
8
Modeling cell biological features of meiotic chromosome pairing to study interlock resolution.模拟减数分裂染色体配对的细胞生物学特征以研究连锁的解开。
PLoS Comput Biol. 2022 Jun 13;18(6):e1010252. doi: 10.1371/journal.pcbi.1010252. eCollection 2022 Jun.
9
De-dimerization of PTB is catalyzed by PDI and is involved in the regulation of p53 translation.PTB 的解聚由 PDI 催化,并参与 p53 翻译的调节。
Nucleic Acids Res. 2021 Sep 20;49(16):9342-9352. doi: 10.1093/nar/gkab708.
10
Bioactive Olivacine Derivatives-Potential Application in Cancer Therapy.生物活性橄榄酰胺衍生物——在癌症治疗中的潜在应用
Biology (Basel). 2021 Jun 21;10(6):564. doi: 10.3390/biology10060564.